radiation-therapy

Documents about radiation-therapy

• Sunitinib, Cetuximab, and Radiation Therapy in Treating Patients With Locally Advanced or Recurrent Squamous Cell Carcinoma of the Head and Neck#917831ClinicalTrials.gov
• Chemotherapy, Radiation Therapy, and Cetuximab in Treating Patients With the Head and Neck Cancer#887818ClinicalTrials.gov
• Radiation Therapy With or Without Chemotherapy in Treating Patients With Advanced Head and Neck Cancer#904101ClinicalTrials.gov
• Docetaxel and S-1 Followed By Radiation Therapy and Low-Dose Cisplatin in Treating Patients With Stage III or Stage IV Head and Neck Cancer#905159ClinicalTrials.gov
• Radiation Therapy and Chemotherapy in Treating Patients With Head and Neck Cancer#896335ClinicalTrials.gov
• Erlotinib, Docetaxel, and Radiation Therapy in Stage III or Stage IV Squamous Cell Carcinoma of the Head and Neck#828876ClinicalTrials.gov
• Bortezomib, Cetuximab, and Radiation Therapy With or Without Cisplatin in Treating Patients With Stage IV Head and Neck Cancer#908420ClinicalTrials.gov
• Fosaprepitant Dimeglumine, Palonosetron Hydrochloride, and Dexamethasone in Preventing Nausea and Vomiting Caused by Cisplatin in Patients With Stage III or Stage IV Head and Neck Cancer Undergoing Chemotherapy and Radiation Therapy#905193ClinicalTrials.gov
• Biomarkers in Predicting Response to Treatment in Patients With Newly Diagnosed Stage III or Stage IV Head and Neck Cancer Treated With Carboplatin, Paclitaxel, and Radiation Therapy#900806ClinicalTrials.gov
• Cisplatin, Intensity-Modulated Radiation Therapy, and Pembrolizumab in Treating Patients With Stage III-IV Head and Neck Squamous Cell Carcinoma#803913ClinicalTrials.gov
• Onalespib in Treating Patients With Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck Receiving Radiation Therapy and Cisplatin#883387ClinicalTrials.gov
• Yale-New Haven Hospital Annual Report 1974#1027022EliScholar